Skip to main content

Table 1 Primer sequences and primer products

From: Association study between common variations in some candidate genes and prostate adenocarcinoma predisposition through multi-stage approach in Iranian population

 

rs721048

rs4242382

rs16901979

rs1447295

rs2735839

Forward inner

CCCTGAGGATTATCAAGGTCCCTTTGA

GAACATTTTGTCCCTCTAGTTATCTTCACG

AGCAGTGTTAATGATTTAGCATTACTTGTA

AAGTGCCATTGGGGAGGTATGTAAGAC

GCCTAGGGATCTGGTTCTGTCTTGTGGACG

Reverse inner

CTGTTCCACACTGAGGTCCTTATGCC

TACTGCCTGATTCTTGATGGGCCGGT

TATCTCAAAAATACCATTTGCCAAAG

TCCTGTTGCTTTTTTTCCATAGCGCT

CCTTCTTGGGATAGCCCCATGGTCCAATT

Forward outer

TCCGAGTACTTCCTCACATAAACCCTGTG

TTCTCTTTTCCATTCCTGTCCTCTCCC

ACATATTTCAGAGGCACATAACTCAA

ATTCTAGAACACATATTGCCTGCCACTGA

CTGTTAGCATGAATCATCTGGCACGGCC

Reverse outer

AGCATGAATTTAGGGTGGCAGAGAGAGA

TTATGAACATCTGCATAGAGGGACGCTG

TATAACAACATTTTGCTCCATCAGTTAC

CTTAAATTTCTTTTCCTCCCAGATTTTCCC

TAACCTCAGGGTGGGAATTCCTCCAGCA

Primer products

A (mutant) = 268 bp

G (wild) = 354 bp

A/G = 268/354 bp

C+ = 569 bp

G (wild) = 233 bp

A (mutant) = 355 bp

A/G = 355/233 bp

C+ = 532 bp

A (mutant) = 278 bp

C (wild) = 323 bp

A/C = 278/323 bp

C+ = 545 bp

C (wild) = 152 bp

A (mutant) = 228 bp

A/C = 228/152 bp

C+ = 327 bp

G (wild) = 179 bp

A (mutant) = 268 bp

A/G = 268/179 bp

C+ = 388 bp